Superoxide dictates the mode of U937 cell ascorbic acid uptake and prevents the enhancing effects of the vitamin to otherwise nontoxic levels of reactive oxygen/nitrogen species

Journal of Nutritional Biochemistry

Volumn 24, Issue 2, 2013, Pages 467-474

  Fiorani, Mara ^a   Azzolini, Catia ^a   Cerioni, Liana ^a   Guidarelli, Andrea ^a   Cantoni, Orazio ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Cell death; Reactive oxygen nitrogen species; Superoxide; U937 cells; Vitamin C uptake

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASCORBATE OXIDASE; ASCORBIC ACID; DEHYDROASCORBIC ACID; HYDROGEN PEROXIDE; PEROXYNITRITE; PROTEIN BAX; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TERT BUTYL HYDROPEROXIDE; XANTHINE; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MYELOID LEUKEMIA;

ASCORBATE OXIDASE; ASCORBIC ACID; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; DEHYDROASCORBIC ACID; HUMANS; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PEROXYNITROUS ACID; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TERT-BUTYLHYDROPEROXIDE; XANTHINE OXIDASE;

EID: 84872820158     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.01.009     Document Type: Article

References (48)

1. Frei B., England L., Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989, 86:6377-6381.
2. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic Res 1996, 25:439-454.
3. Sestili P., Brandi G., Brambilla L., Cattabeni F., Cantoni O. Hydrogen peroxide mediates the killing of U937 tumor cells elicited by pharmacologically attainable concentrations of ascorbic acid: cell death prevention by extracellular catalase or catalase from cocultured erythrocytes or fibroblasts. J Pharmacol Exp Ther 1996, 277:1719-1725.
4. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998, 392:559.
5. Clement M.V., Ramalingam J., Long L.H., Halliwell B. The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid Redox Signal 2001, 3:157-163.
6. Chen Q., Espey M.G., Sun A.Y., Lee J.H., Krishna M.C., Shacter E., Choyke P.L., Pooput C., Kirk K.L., Buettner G.R., Levine M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A 2007, 104:8749-8754.
7. 2 induced oxidative DNA damage in Jurkat cells. Free Radic Biol Med 2006, 40:2071-2079.
8. 2-induced damage and iron homeostasis in human cells. Free Radic Biol Med 2007, 43:1165-1175.
9. Verrax J., Cadrobbi J., Marques C., Taper H., Habraken Y., Piette J., Calderon P.B. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death. Apoptosis 2004, 9:223-233.
10. Guidarelli A., De Sanctis R., Cellini B., Fiorani M., Dacha M., Cantoni O. Intracellular ascorbic acid enhances the DNA single-strand breakage and toxicity induced by peroxynitrite in U937 cells. Biochem J 2001, 356:509-513.
11. Guidarelli A., Fiorani M., Cantoni O. Enhancing effects of intracellular ascorbic acid on peroxynitrite-induced U937 cell death are mediated by mitochondrial events resulting in enhanced sensitivity to peroxynitrite-dependent inhibition of complex III and formation of hydrogen peroxide. Biochem J 2004, 378:959-966.
12. Rose R.C. Transport of ascorbic acid and other water-soluble vitamins. Biochim Biophys Acta 1988, 947:335-366.
13. Dhariwal K.R., Hartzell W.O., Levine M. Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 1991, 54:712-716.
14. Wilson J.X. Regulation of vitamin C transport. Annu Rev Nutr 2005, 25:105-125.
15. Vera J.C., Rivas C.I., Zhang R.H., Farber C.M., Golde D.W. Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid. Blood 1994, 84:1628-1634.
16. Nualart F.J., Rivas C.I., Montecinos V.P., Godoy A.S., Guaiquil V.H., Golde D.W., Vera J.C. Recycling of vitamin C by a bystander effect. J Biol Chem 2003, 278:10128-10133.
17. Corti A., Casini A.F., Pompella A. Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch Biochem Biophys 2010, 500:107-115.
18. Agus D.B., Vera J.C., Golde D.W. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res 1999, 59:4555-4558.
19. Vera J.C., Rivas C.I., Zhang R.H., Golde D.W. Colony-stimulating factors signal for increased transport of vitamin C in human host defense cells. Blood 1998, 91:2536-2546.
20. Azzolini C., Fiorani M., Guidarelli A., Cantoni O. Studies with low micromolar levels of ascorbic and dehydroascorbic acid fail to unravel a preferential route for vitamin C uptake and accumulation in U937 cells. Br J Nutr 2011, 1-6. [Epub ahead of print].
21. 2 in U937 cells: the extent of arachidonic acid formation regulates the balance between cell survival or death. Cell Death Differ 2002, 9:1368-1376.
22. Savini I., Duflot S., Avigliano L. Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent. Biochem J 2000, 345:665-672.
23. Perez-Cruz I., Carcamo J.M., Golde D.W. Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 2003, 102:336-343.
24. - production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol 1984, 105:358-365.
25. Cantoni O., Tommasini I., Cerioni L. The arachidonate-dependent survival signaling preventing toxicity in monocytes/macrophages exposed to peroxynitrite. Methods Enzymol 2008, 441:73-82.
26. Halestrap A.P., Connern C.P., Griffiths E.J., Kerr P.M. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 1997, 174:167-172.
27. Henke W., Jung K. Comparison of the effects of the immunosuppressive agents FK 506 and cyclosporin A on rat kidney mitochondria. Biochem Pharmacol 1993, 46:829-832.
28. Childs A., Jacobs C., Kaminski T., Halliwell B., Leeuwenburgh C. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med 2001, 31:745-753.
29. Fisher A.E., Naughton D.P. Vitamin C contributes to inflammation via radical generating mechanisms: a cautionary note. Med Hypotheses 2003, 61:657-660.
30. Rees D.C., Kelsey H., Richards J.D. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ 1993, 306:841-842.
31. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
32. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424.
33. Leung P.S., Chan Y.C. Role of oxidative stress in pancreatic inflammation. Antioxid Redox Signal 2009, 11:135-165.
34. May J.M., Mendiratta S., Qu Z.C., Loggins E. Vitamin C recycling and function in human monocytic U-937 cells. Free Radic Biol Med 1999, 26:1513-1523.
35. Kc S., Carcamo J.M., Golde D.W. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 2005, 19:1657-1667.
36. Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem Biophys Res Commun 1975, 63:463-468.
37. Berenson J.R., Matous J., Swift R.A., Mapes R., Morrison B., Yeh H.S. A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma. Clin Cancer Res 2007, 13:1762-1768.
38. Grad J.M., Bahlis N.J., Reis I., Oshiro M.M., Dalton W.S., Boise L.H. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 2001, 98:805-813.
39. Rollig C., Illmer T. The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review. Cancer Treat Rev 2009, 35:425-430.
40. Cerioni L., Cantoni O. ERK1/2 regulates two sequential steps promoting monocyte survival to peroxynitrite. J Cell Physiol 2007, 210:177-182.
41. 2 signals monocyte/macrophage survival to peroxynitrite via protein kinase A converging in bad phosphorylation with the protein kinase C alpha-dependent pathway driven by 5-hydroxyeicosatetraenoic acid. J Immunol 2008, 181:5637-5645.
42. Tommasini I., Guidarelli A., Cerioni L., Cantoni O. The arachidonate-dependent cytoprotective signaling evoked by peroxynitrite is a general response of the monocyte/macrophage lineage. Biochem Biophys Res Commun 2004, 316:1191-1195.
43. Tommasini I., Guidarelli A., Palomba L., Cerioni L., Cantoni O. 5-Hydroxyeicosatetraenoic acid is a key intermediate of the arachidonate-dependent protective signaling in monocytes/macrophages exposed to peroxynitrite. J Leukoc Biol 2006, 80:929-938.
44. Mandl J., Szarka A., Banhegyi G. Vitamin C: update on physiology and pharmacology. Br J Pharmacol 2009, 157:1097-1110.
45. McLaran C.J., Bett J.H., Nye J.A., Halliday J.W. Congestive cardiomyopathy and haemochromatosis-rapid progression possibly accelerated by excessive ingestion of ascorbic acid. Aust N Z J Med 1982, 12:187-188.
46. Gerster H. High-dose vitamin C: a risk for persons with high iron stores?. Int J Vitam Nutr Res 1999, 69:67-82.
47. Galley H.F., Davies M.J., Webster N.R. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 1996, 20:139-143.
48. Bryer S.C., Goldfarb A.H. Effect of high dose vitamin C supplementation on muscle soreness, damage, function, and oxidative stress to eccentric exercise. Int J Sport Nutr Exerc Metab 2006, 16:270-280.